ID | JOS-bpb.b20-00221 |
著者:名前 | |
著者:別形式 | Takeuchi, Tomoharu / Horimoto, Yasuhiro / Oyama, Midori / Nakatani, Sachie / Kobata, Kenji / Tamura, Mayumi / Arata, Yoichiro / Hatanaka,Tomomi |
著者:カナ | |
著者:所属 | 城西大学薬学部 / 城西大学薬学部 / 城西大学薬学部 / 城西大学薬学部 / 城西大学薬学部 / 帝京大学薬学部 / 帝京大学薬学部 / 城西大学薬学部 |
著者:所属(別形式) | Josai University, Faculty of Pharmacy and Pharmaceutical Sciences / Josai University, Faculty of Pharmacy and Pharmaceutical Sciences / Josai University, Faculty of Pharmacy and Pharmaceutical Sciences / Josai University, Faculty of Pharmacy and Pharmaceutical Sciences / Josai University, Faculty of Pharmacy and Pharmaceutical Sciences / Teikyo University, Faculty of Pharma-Science / Teikyo University, Faculty of Pharma-Science / Josai University, Faculty of Pharmacy and Pharmaceutical Sciences |
著者版フラグ | publisher |
出版地 | 東京 |
出版者 | 日本薬学会 |
出版者:カナ | ニホンヤクガクカイ |
出版者:別名 | The Pharmaceutical Society of Japan |
NCID | AA10885497 |
冊子ISSN | 09186158 |
電子ISSN | 13475215 |
掲載誌名 | |
巻 | 43 |
号 | 10 |
刊行年月 | 2020-10 |
開始ページ | 1501 |
終了ページ | 1505 |
コンテンツ作成日 | 2020-03-10 |
コンテンツ修正日 | 2020-07-05 |
コンテンツ登録日 | 2020-11-26 |
識別番号:DOI | info:doi/10.1248/bpb.b20-00221 |
識別番号:DOI(リンク) | |
抄録 | Osteoclasts are the only bone-resorbing cells in organisms and understanding their differentiation mechanism is crucial for the treatment of osteoporosis. In the present study, we investigated the effect of Thiamet G, an O-GlcNAcase specific inhibitor, on osteoclastogenic differentiation. Thiamet G treatment increased global O-GlcNAcylation in murine RAW264 cells and suppressed receptor activator of nuclear factor-κB ligand (RANKL)-dependent formation in tartrate-resistant acid phosphatase (TRAP)-positive multinuclear cells, thereby suppressing the upregulation of osteoclast specific genes. Meanwhile, knockdown of O-linked N-acetylglucosamine (O-GlcNAc) transferase promoted the formation TRAP-positive multinuclear cells. Thiamet G treatment also suppressed RANKL and macrophage colony-stimulating factor (M-CSF) dependent osteoclast formation and bone-resorbing activity in mouse primary bone marrow cells and human peripheral blood mononuclear cells. These results indicate that the promotion of O-GlcNAc modification specifically suppresses osteoclast formation and its activity and suggest that chemicals affecting O-GlcNAc modification might potentially be useful in the prevention or treatment of osteoporosis in future. |
キーワード | |
言語 | eng |
資源タイプ | text |
ジャンル | |
フォーマット | application/pdf |
権利 | Copyright © 2020 The Pharmaceutical Society of Japan |
このアイテムを表示する:本文(pdf) | ( 719.1KB) ダウンロード回数: 回 |
このアイテムを表示する:URI | |